Page 1
Biochemical and Biophysical Research Communications 315 (2004) 664–670
BBRCwww.elsevier.com/locate/ybbrc
Basis for fusion inhibition by peptides: analysis of the heptadrepeat regions of the fusion proteins from Nipah and Hendra
viruses, newly emergent zoonotic paramyxoviruses
Yanhui Xu,a Shan Gao,a,b,c David K. Cole,d Junjie Zhu,b Nan Su,a Hui Wang,c
George F. Gao,d,* and Zihe Raoa,*
a Laboratory of Structural Biology, Tsinghua University, Beijing 100084, Chinab Beijing Municipal Station of Animal Husbandry and Veterinary Medicine, Beijing, China
c Centre for Ecology and Hydrology, Oxford (CEH-Oxford), Mansfield Road, Oxford OX1 3SR, UKd Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford OX3 9DU, UK
Received 22 January 2004
Abstract
Nipah virus (NiV) and Hendra virus (HeV) are novel zoonotic members of the Paramyxoviridae family and are the prototypes
for a newly designated genus, Genus Henipavirus. Recent studies have shown that paramyxovirus might adopt a similar mechanism
of virus fusion-entry. Under this mechanism, the two highly conserved heptad repeat (HR) regions, HR1 and HR2, in the fusion (F)
protein, seem to show characteristic structure in the fusion core: the formation of a 6-helix coiled-coil bundle. The three HR1s form
the a-helix coiled-coil surrounded by three HR2s. In this study, the two HR regions of NiV or HeV were expressed in an Escherichia
coli system as a single chain and the results do show that HR1 and HR2 interact with each other in both NiV and HeV and form
typical 6-helix coiled-coil bundles. This provides the molecular basis of HR2 inhibition to NiV and HeV fusion as observed in an
earlier report.
� 2004 Elsevier Inc. All rights reserved.
Keywords: Nipah virus; Hendra virus; Heptad repeat; Fusion
Nipah virus (NiV) is an emerging pathogen identified
in 1999 responsible for the disease transmitted from pigs
to humans [1,2]. Hendra virus (HeV) emerged in 1994
and was transmitted to humans from close contact with
horses [3,4]. Therefore, they are potential zoonosis and
pathogens related to bio-terrorism [5–7]. Both NiV andHeV are unusual among the paramyxoviruses in their
abilities to infect and cause potentially fatal disease
(encephalitis) in a number of hosts, including human
beings [5,6]. These two viruses also have exceptionally
larger genomes than any other members of paramyx-
oviruses [5,8,9]. Phylogenetic analysis of their genomes
shows that they are distinct members of Family Para-
* Corresponding authors. Fax: +44-1865-222901 (G.F. Gao),
+86-10-62773145 (Z. Rao).
E-mail addresses: [email protected] (G.F. Gao), raozh@
xtal.tsinghua.edu.cn (Z. Rao).
0006-291X/$ - see front matter � 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2004.01.115
myxoviridae, but are closely related to members in Ge-
nus Morbillivirus and Genus Respirovirus [8,9], in which
measles virus (MeV) and Sendai virus (SeV) are mem-
bers, respectively. They have been now classified as a
new genus, Genus Henipavirus, inside the Family Para-
myxoviridae [5,6].Paramyxoviruses are enveloped negative-stranded
RNA viruses, forming a large family (Family Para-
myxoviridae) sub-divided into two subfamilies with five
established and two newly defined genera (Genus Ru-
bulavirus, Respirovirus, Morbillivirus, Pneumovirus,
Metapnuemovirus, and the new Avulavirus, Henipavirus)
[6,10,11]. As with other paramyxoviruses, NiV and HeV
consist of two surface glycoproteins on the viral enve-lope, fusion (F) protein and glycoprotein (G protein,
also called attachment protein) [8,9,12,13]. These two
glycoproteins are responsible for the virus fusion and
entry into host cells [12,13]. G protein initiates the
Page 2
Y. Xu et al. / Biochemical and Biophysical Research Communications 315 (2004) 664–670 665
infection by binding to the cellular receptor (attach-ment) but F protein mediates the actual virus–cell
membrane fusion process [12–14]. F protein is initially
synthesized as a precursor, F0, then being cleaved into
F1 and F2 by a furin-like enzyme derived from the host
(there is some evidence, at least in HeV, that the enzyme
involved in this cleavage is not furin) [15]. F1 and F2 are
linked by a disulfide bond forming a trimer on the virus
surface. In the attachment and subsequent fusion pro-cess of the paramyxoviruses, the F protein undergoes a
series of conformational changes under which virus and
cell membrane fusion occurs [14,16,17].
It is known that some protein modules of the F
protein are crucial for the conformational changes
during the membrane fusion [16–21]. Among them, fu-
sion peptide (FP) is highly hydrophobic and is respon-
sible for direct insertion of the F protein into the cellularlipid membrane [16,17,22], whereas the highly conserved
heptad repeat (HR) regions in F1, HR1 and HR2, act
seemingly as scaffolding modules. During the confor-
mational changes in the fusion process, HR1 and HR2
interact with each other to form a so-called “trimer
of 2HR” or “6-helix bundle,” in which three HR1s
form a central trimeric coiled-coil surrounded by three
a-helix-structured HR2s in an anti-parallel manner[16,17,23,24]. The formation of this 6-helix bundle pulls
the viral and cellular membranes toward each other,
thereof facilitating the membrane fusion. Blocking of
the formation of this 6-helix bundle can inhibit the viral
fusion and infection. Introduction of exogenous soluble
HR1 or HR2 into the virus infection system in vitro
could inhibit viral infection by competing with the en-
dogenous HR1/HR2 interaction [17], holding the con-formational-changing F protein in the intermediate state
[17]. It has also been shown that the philosophy by in-
troducing soluble HR2 into HIV-infected patients does
work in vivo [25]. In a recent study involving HR2 of
NiV and HeV, strong inhibition was observed in the in
vitro cell-fusion system of the viruses [26]. However, the
interaction of HR1 and HR2 in NiV or HeV has not
been studied. Therefore in this study, we have used acomputer program called LearnCoil-VMF [27], de-
signed specifically for identifying viral membrane HR
coiled-coil regions, to predict the precise position of
both HR1 and HR2 in NiV and HeV F proteins. The
predicted HR1 regions are identical for NiV and HeV
but with a two-amino-acid difference in the HR2 re-
gions. Subsequently, a single chain of HR1 and HR2 for
both NiV and HeV was expressed in the Escherichia coli
system used previously for other paramyxoviruses [28–
34]. Biochemical and biophysical analyses of this poly-
peptide confirmed the formation of a 6-helix bundle,
indicating the typical characteristics of NiV and HeV F
proteins as members of the Paramyxoviridae family and
providing the molecular basis for HR2 inhibiting effect
on the viral fusion. The results also show that HR2 of
NiV and HeV are functionally and structurally inter-changeable.
Materials and methods
Prediction of the heptad repeat regions and construction of the ex-
pression vectors. The a-helix structure of the two heptad repeat regions
of the F proteins of NiV and HeV (GenBank Accession Nos.
AAK29087.1 for NiV and AAC83192.2 for HeV) was predicted by
LearnCoil-VMF program (http://nightingale.lcs.mit.edu/cgi-bin/vmf),
which was specifically developed for identification of potential coiled-
coil heptad repeat regions in viral fusion proteins by Kim and col-
leagues [27] at Massachusetts Institute of Technology.
The genes encoding the HR1 and HR2 regions of NiV were syn-
thesized by PCR using eight synthesized primers according to the
published sequences (GenBank Accession No. AAK29087.1). The
codon usage was optimized according to E. coli expression preferences.
HR1 and HR2 were connected by an eight-amino-acid linker
(GGSGGSGG, single-letter abbreviation of amino acids) and a 6-His
tag was introduced at the C-terminus to facilitate the protein purifi-
cation. A rhinovirus 3C protease cleavage site (EVLFQ+GP, single-
letter abbreviation of amino acids) [35] was introduced between the
end of the HR2 and the 6-His tag by PCR for the purpose of 6-His
removal to facilitate the crystallization. The gene of 2-Helix with NcoI–
BamHI sites (these sites were introduced by PCR primers) at the ends
was inserted into the NcoI–BamHI restriction sites of the pET ex-
pression vector pET-23d (Novagen). A stop codon was introduced
immediately before the BamHI restriction site. This construct was
named as 23NiV-2-Helix (Fig. 1). The construction was verified by
direct DNA sequencing.
The primers overlapped with each other for 8–16 nucleotide bases.
The NcoI and BamHI restriction sites were added in primers P1 and P8
(capitalized/italic denominators). The gene of NiV 2-Helix was ob-
tained by two-step PCR. First, the eight synthetic primers (0.2OD/ll)were mixed and the PCRs were run with the following conditions:
denatured at 94 �C for 5min and then 25 cycles of 94 �C 1.5min, 55 �C2min, and 72 �C 1min; For the second PCR, the first PCR product
was used as template and new PCR product was amplified by using
primers P1 and P8 at the same condition as the first PCR.
Primers used for making the NiV 2-Helix construct:
P1: 50-ggcatgCCATGGctatgaaaaacgctgacaacatcaacaaactgaaatcttcca-30
P2: 50-gaccgctctgcaggactatggtggctctggcggttccggtggcaaagttg-30
P3: 50-gctgcagagactggttcatagaagagatctgagaagagatgtcaactttg-30
P4: 50-ttaaactgcaggaaaccgctgaaaaaactgtttatgttctgaccgctctg-30
P5: 50-tccagcagacgctgagcttctttgatatagtctttagactgctgcagaga-30
P6: 50-aaactgaaatcttccatcgaatctaccaacgaagctgttgttaaactgca-30
P7: 50-atggtgatgcggaccctggaacagaacttcgttaacggtgtccagcagac-30
P8: 50-gggcccaagcttGGATCCctagtgatggtgatggtgatgcggaccctggaacag-30.
As the HR1 sequences of NiV and HeV are identical with only two-
amino-acid substitutions (RL)KI, single-letter amino acid abbrevi-
ation used) in HR2 between them (Fig. 1), the HeV 2-Helix construct
was made by using the QuickChange technique (Strategene) with the
following primers. The nucleotide sequences of the mutated amino
acids in the primers are indicated with bold italic capital letters in the
boxes. The construct was named as 23HeV-2-Helix.
Primer 1, 50-CAAAGAAGCTCAGAAGATC CTGGACACCGT
TAACG-30
Primer 2, 50-CGGTGTCCAGGATCTTCTGAGCTTCTTTGAT
ATAGTC-30.
Protein expression, purification, and gel-filtration analysis. The re-
combinant pET23d plasmids (23NiV-2-Helix or 23HeV-2-Helix) were
transformed into E. coli strain BL21 (DE3). A single colony of the
bacteria was grown at 37 �C in LB medium to an optical density of 0.6
Page 3
Fig. 1. Prediction of the heptad repeat regions and the construction strategy of the 2-Helix protein construct for both NiV and HeV F proteins. (A)
Schematic diagram of NiV and HeV F proteins with the location of structurally significant domains indicated. The listed sequences of HR1 (137–178)
and HR2 (453–485) used in this study were derived from the LearnCoil-VMF prediction program [27]. There are only two amino acid differences
(479–480, RL)KI) in HR1 and HR2 regions (located in HR2) between NiV and HeV as indicated. (B) Two coiled-coil-like regions are predicted by
LearnCoil-VMF with high likelihood. (C) Schematic representation of the 2-Helix protein construct of HR1 and HR2 connected by an eight-amino-
acid linker is as indicated. (D) Helix wheel analysis of the predicted coiled-coil regions of NiV F HR1 and HR2. Please note the two mutations of
HeV relative to NiV were located at positions g and f of the helix wheel, not at a or d which are important for central HR1 trimer formation. The
mutations of RL)KI are also conserved changes.
666 Y. Xu et al. / Biochemical and Biophysical Research Communications 315 (2004) 664–670
(OD600nm) before induction with 1mM IPTG for 4 h. Bacterial cells
were harvested and lysed by sonication in phosphate-buffered saline
(PBS, 10mM sodium phosphate, pH 7.4; 150mM NaCl). The lysates
were clarified by centrifugation at 15,000 rpm for 15min at 4 �C. Theclarified supernatants were passed through Ni–NTA agarose column
(Qiagen) that was equilibrated with PBS. The histidine-tagged protein
bound column was washed with washing buffer (1� PBS, 100mM
imidazole) over 10 column volumes and eluted with elution buffer (1�PBS, 500mM imidazole) for five column volumes. The resultant pro-
tein 2-Helix was dialyzed against PBS and concentrated to a proper
concentration by ultrafiltration (5 kDa cut-off). Proteins were analyzed
by 15% SDS–PAGE. Protein concentration was determined using the
BCA protein determination assay (Pierce Biochemicals). The purified
2-Helix protein (0.5ml) was loaded onto a Superdex 75 HR10/30
(Pharmacia Biotech) column with an Akta Purifier System (Pharmacia
Biotech). The fractions of the peak were collected and analyzed by a
15% SDS–PAGE. The peak molecular weight was estimated by com-
parison with the protein standards run on the same column.
Chemical cross-linking of the complex. This was carried out essen-
tially as described earlier [28]. Briefly the gel-filtration purified 2-Helix
Page 4
Y. Xu et al. / Biochemical and Biophysical Research Communications 315 (2004) 664–670 667
protein was dialyzed against cross-linking buffer (50mM Hepes, pH
8.3; 100mM NaCl) and concentrated to approximately 2mg/ml by
ultrafiltration (5 kDa cut-off). Proteins were cross-linked with ethyl-
eneglycol bis(-succinimidylsuccinate) (EGS) (Sigma). The reactions
were incubated for 1 h on ice at different concentrations of EGS, re-
spectively (0, 0.03, 0.1, 0.3, 0.7, and 1.5mM EGS), and quenched with
50mM glycine. Cross-linked samples were analyzed under reducing
conditions by 15% SDS–PAGE.
CD spectroscopic analysis. Circular dichroism (CD) spectra were
performed on a Jasco J-715 spectrophotometer. The working buffer
was PBS (10mM sodium phosphate, pH 7.3; 150mM NaCl). Wave-
length spectra were recorded at 25 �C using a 0.1-cm path-length cu-
vette. Thermodynamic stability was measured at 222 nm by recording
the CD signals in the temperature range of 20–90 �C with a scan rate of
1 �C/min. For the CD spectra of the re-natured protein, denatured
protein (at 90 �C) was cooled down on ice and then tested for CD
spectra at 25 �C.Protein crystallization. Proteins were concentrated to 20mg/ml in
25mM Tris–HCl and 25mM NaCl, pH 8.0. Initial crystallization
conditions were screened by using the hanging-drop vapor diffusion
method with sparse matrix crystallization kits (Crystal Screen I and II,
Hampton Research, Riverside, CA). One microliter of protein solution
was mixed with 1ll reservoir solution and equilibrated against 200llof the reservoir solution. The crystallization trays were kept at 18 �C.
Fig. 3. Gel-filtration analysis of the purified NiV 2-Helix protein. The
inset picture is of the proteins collected from the peak analyzed on 15%
SDS–PAGE. Clearly the symmetrical peak gives rise to a 2-Helix
protein (NP). From the estimated molecular weight in comparison
with the standards (14 and 52 kDa), the 2-Helix most likely forms
trimer (30 kDa). Results from HeV 2-Helix showed the same peak
(data not shown).
Results and discussion
HR1 and HR2 interact with each other to form a stable
complex
By using the LearnCoil-VMF program, two HR re-
gions were identified in the ectodomain of the fusion
protein for both NiV and HeV (Figs. 1A and B). HR1 is
located at the carboxyl terminus of the fusion peptide
which lies at the beginning of the F1 N-terminus. HR2 is
located adjacent to the amino terminus of the trans-
membrane domain. Consistent with that of other para-
myxovirus members, the two HR regions of these twoviruses span 275 amino acid residues, different from vi-
ruses of other families, such as Filoviridae and Retro-
viridae. Helical wheel drawing (Fig. 1D) showed that
positions “a” and “d” on both HR1 and HR2, which are
Fig. 2. SDS–PAGE analysis of the expression and purification of the 2-Helix
induced (final concentration is 1mM); lane 3, purified 2-Helix protein; and
important for coiled-coil structure [17,19], often consistof typical hydrophobic amino acids, e.g., leucine (L),
isoleucine (I) or valine (V).
The schematic representation of the construct
(23NiV-2-Helix or 23NiV-2-Helix) of HR1, linker, and
HR2 (2-Helix) is shown in Fig. 1C. The 2-Helix proteins
were expressed as soluble proteins in E. coli (Fig. 2) and
recovered from the supernatants of the cell lysates. The
purified proteins were concentrated to 20–30mg/ml inPBS and analyzed by gel-filtration and chemical cross-
linking for estimation of the molecular weight. The
2-Helix protein was eluted between the corresponding
position of 52 and 14.4 kDa (Fig. 3). In comparison, the
computed molecular weight of 2-Helix (with 6� histi-
dine) is about 10 kDa, which indicates that the 2-Helix
might form oligomers (30 kDa). Subsequently, chemical
cross-linking demonstrated that the 2-Helix protein ol-igomer was, in fact, a trimer (Fig. 4), although the
monomer/dimer bands could also be found even in high
concentrations of the cross-linker. In addition, the
content of trimer increased with the concentration
proteins of NiV (A) and HeV (B). Lane 1, Non-induced; lane 2, IPTG
lane M, molecular weight standards in kDa.
Page 5
Fig. 4. Chemical cross-linking of the NiV 2-Helix protein with different
concentrations of chemical cross-linker, EGS (ethyleneglycol bis-
succinimidylsuccinate, from Sigma). Cross-linked products were sep-
arated on a 15% SDS–PAGE followed by Coomassie brilliant blue
staining. Protein markers (M) are shown in kDa. Numbers 1–6 indi-
cate the concentrations of the EGS used (1.5, 0.7, 0.3, 0.1, 0.03, and
0mM, respectively). Bands corresponding to monomer, dimer, and
trimer are indicated. Similar profiles were obtained with HeV 2-Helix
preparation (data not shown).
Fig. 6. Typical crystals of the NiV (A) and HeV (B) 2-Helix proteins
grown with hanging-drop method in 29% PEG 4000, 0.1M Tris, pH
8.5 (NiV) and 10% PEG 4000, 0.1M Hepes, pH 6.5 (HeV).
668 Y. Xu et al. / Biochemical and Biophysical Research Communications 315 (2004) 664–670
increase of the chemical cross-linker. All this indicates
that HR1 interacts with HR2, forming stable trimeric
complex.
2-Helix complex forms characteristic 6-helix bundle
The secondary structure of the 2-Helix protein was
examined by CD spectroscopy as described in Materialsand methods. The absorption curve showed that the 2-
Helix protein had double minima at 208 and 222 nm
(Fig. 5A), consistent with typical a-helix structure. The
thermal stability test indicated that trimer formation of
the 2-Helix was very stable in PBS (Figs. 5B and C),
suggesting that the 2-Helix trimer represents the core
structure of the post-fusion state of the coiled-coil
bundle, as thoroughly studied for other viruses [16–21].Denature–renature process could recover the stable he-
lix structure (Fig. 5C).
Crystals in different forms could be obtained in PEG
4000, pH 8.5, with the hanging-drop method as shown
Fig. 5. The CD spectra and thermal stability measurement of the NiV 2-H
secondary structure measured at 25 �C. (B) Thermal stability was recorded at
the re-natured 2-Helix protein from the denatured sample on 90 �C. Similar
in Fig. 6A for the NiV 2-Helix protein; in 10% PEG4000, 0.1M Hepes, pH 6.5, for HeV 2-Helix protein
(Fig. 6B). Efforts are being made currently to optimize
the crystallization conditions for better X-ray diffracting
crystals, ultimately to solve the atomic structure of this
6-helix coiled coil, for both NiV and HeV.
2-Helix proteins of NiV and HeV behave similarly
As described in Materials and methods, the 2-Helix
construct of HeV was obtained by site-directed muta-
genesis of the NiV 2-Helix. This protein was then ex-
pressed and purified essentially with the same method as
that used for NiV 2-Helix (Fig. 2B). All the biochemicaland biophysical analyses of the HeV 2-Helix protein, in-
cluding gel-filtration, chemical cross-linking, and circular
dichroism, were carried out and the results show clearly
that HeV 2-Helix also forms stable 6-helix bundle (data
not shown). This indicates that the two-amino-acid
polymorphism in the HR2 region of HeV does not affect
the binding ofHR1 andHR2. In an earlier report, Bossart
et al. [26] showed that HR2 derived from either HeV or
elix proteins in PBS. (A) The 2-Helix proteins show a typical a-helix222 nm. The Tm is approximately 85 �C. (C) The CD spectra at 25 �C of
results were recorded with HeV 2-Helix protein (data not shown).
Page 6
Y. Xu et al. / Biochemical and Biophysical Research Communications 315 (2004) 664–670 669
NiV gave cross-inhibition to NiV or HeV fusion withsimilar effects in an in vitro cell system. These data indi-
cate that the HR2 of NiV and HeV is structurally and
functionally interchangeable. This is clearly consistent
with the conserved two-amino-acid polymorphism
(RL)KI) in the HR2 region between the two viruses.
Implications for virus–cell fusion and entry of NiV and
HeV
NiV and HeV have been convincingly identified as
members of Family Paramyxoviridae with some specific
characters, forming a new genus in the family termed
Genus Henipavirus [5,6,8,9]. Our results here showedthat their heptad repeat regions, HR1 and HR2, interact
with each other to form typical stable 6-helix coiled-coil
bundle, which represents the fusion core of the F protein
[16,17]. This provides further evidence that both viruses
are typical paramyxoviruses in terms of virus entry.
Bossart et al. [26] found that HR2s derived from either
NiV or HeV are potent fusion inhibitors for both viruses
and the inhibition effects are interchangeable. This isconsistent with the observations made in this study. The
basis of this interchangeable interaction awaits a solu-
tion by crystal structures of the 6-helix bundles.
The fusion and entry of the paramyxovirus need two
envelope glycoproteins, attachment and fusion proteins.
In the case of NiV and HeV, they are G and F glyco-
proteins. The fusion of most paramyxoviruses requires
both glycoproteins but with some exceptions, e.g., SV5.It is shown that both G and F proteins are required for
NiV and HeV [12,13,26]. HR1 inhibition to membrane
fusion or virus infection of NiV or HeV has not been
tested yet. The inhibition by HR1 might correlate with
the attachment protein requirement: HR1 derived from
those viruses whose fusion absolutely requires attach-
ment proteins does not give rise to fusion inhibition
[32,36–38], whereas HR1 derived from other memberswhose fusion does not absolutely require the attachment
protein does show strong inhibition of virus fusion and
entry [32,39]. It will be of interest to test the HR1 in-
hibition of NiV and HeV in future studies. Evidence
from previous observations of other paramyxoviruses
would suggest that this would not lead to inhibition.
Clear structural analysis of HR 6-helix bundle of NiV
and HeV would provide a detailed picture of the viralfusion core structure and the molecular mechanism
underlying the interchangeable interaction of HR1 with
both NiV and HeV HR2. Our strategy here will be
followed for a structural solution. This will inevitably
add to the repertoire of paramyxovirus 6-helix bundle
fusion core structures, of which only two are available at
present (that of RSV and SV5) [40,41]. This will also
open a new avenue toward the structure-based fusioninhibitor design of peptides, or peptide analogues, e.g.,
small molecules, for these emerging infectious diseases.
Acknowledgments
We thank Dr. Jieqing Zhu for his help during the experimental
procedure and Dr. Catherine Zhang for critical reading of the manu-
script. This work was supported by Project 973 of Ministry of Science
and Technology of China (Grant No. G1999011902). G.F.G.’s stay at
the Tsinghua University was supported by Chunhui Project Scheme of
Ministry of Education, China.
References
[1] K.B. Chua, K.J. Goh, K.T. Wong, A. Kamarulzaman, P.S. Tan,
T.G. Ksiazek, S.R. Zaki, G. Paul, S.K. Lam, C.T. Tan, Fatal
encephalitis due to Nipah virus among pig-farmers in Malaysia,
Lancet 354 (1999) 1257–1259.
[2] K.B. Chua, W.J. Bellini, P.A. Rota, B.H. Harcourt, A. Tamin,
S.K. Lam, T.G. Ksiazek, P.E. Rollin, S.R. Zaki, W. Shieh, C.S.
Goldsmith, D.J. Gubler, J.T. Roehrig, B. Eaton, A.R. Gould, J.
Olson, H. Field, P. Daniels, A.E. Ling, C.J. Peters, L.J. Anderson,
B.W. Mahy, Nipah virus: a recently emergent deadly paramyxo-
virus, Science 288 (2000) 1432–1435.
[3] K. Murray, R. Rogers, L. Selvey, P. Selleck, A. Hyatt, A. Gould,
L. Gleeson, P. Hooper, H. Westbury, A novel morbillivirus
pneumonia of horses and its transmission to humans, Emerg.
Infect. Dis. 1 (1995) 31–33.
[4] K. Murray, P. Selleck, P. Hooper, A. Hyatt, A. Gould, L.
Gleeson, H. Westbury, L. Hiley, L. Selvey, B. Rodwell, P.
Ketterer, A morbillivirus that caused fatal disease in horses and
humans, Science 268 (1995) 94–97.
[5] L. Wang, B.H. Harcourt, M. Yu, A. Tamin, P.A. Rota, W.J.
Bellini, B.T. Eaton, Molecular biology of Hendra and Nipah
viruses, Microbes Infect. 3 (2001) 279–287.
[6] L.F. Wang, B.T. Eaton, Emerging paramyxoviruses, Infect. Dis.
Rev. 3 (2001) 52–69.
[7] J.S. Mackenzie, K.B. Chua, P.W. Daniels, B.T. Eaton, H.E. Field,
R.A. Hall, K. Halpin, C.A. Johansen, P.D. Kirkland, S.K. Lam,
P. McMinn, D.J. Nisbet, R. Paru, A.T. Pyke, S.A. Ritchie, P.
Siba, D.W. Smith, G.A. Smith, A.F. van den Hurk, L.F. Wang,
D.T. Williams, Emerging viral diseases of Southeast Asia and the
Western Pacific, Emerg. Infect. Dis. 7 (2001) 497–504.
[8] L.F. Wang, M. Yu, E. Hansson, L.I. Pritchard, B. Shiell, W.P.
Michalski, B.T. Eaton, The exceptionally large genome of Hendra
virus: support for creation of a new genus within the family
Paramyxoviridae, J. Virol. 74 (2000) 9972–9979.
[9] Y.P. Chan, K.B. Chua, C.L. Koh, M.E. Lim, S.K. Lam, Complete
nucleotide sequences of Nipah virus isolates from Malaysia, J.
Gen. Virol. 82 (2001) 2151–2155.
[10] R.A. Lamb, P.L. Collins, D. Kolakofsky, J.A. Melero, Y. Nagai,
M.B.A. Oldstone, C.R. Pringle, B.K. Rima, Paramyxoviridae, in:
M.H.V. van Regenmortel, C.M. Fauquet, D.H.L. Bishop, E.B.
Carstens, M.K. Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D.J.
McGeoch, C.R. Pringle, R.B. Wicknered (Eds.), Virus Taxonomy:
Classification and Nomenclature of Viruses, Seventh Report,
Academic Press, San Diego, 2000, pp. 549–561.
[11] P.-C. Chang, M.-L. Hsieh, J.-H. Shien, D.A. Graham, M.-S. Lee,
H.K. Shieh, Complete nucleotide sequence of avian paramyxovi-
rus type 6 isolated from ducks, J. Gen. Virol. 82 (2001) 215702168.
[12] K.N. Bossart, L.F. Wang, B.T. Eaton, C.C. Broder, Functional
expression and membrane fusion tropism of the envelope glyco-
proteins of Hendra virus, Virology 290 (2001) 121–135.
[13] A. Tamin, B.H. Harcourt, T.G. Ksiazek, P.E. Rollin, W.J. Bellini,
P.A. Rota, Functional properties of the fusion and attachment
glycoproteins of Nipah virus, Virology 296 (2002) 190–200.
[14] R.A. Lamb, Paramyxovirus fusion: a hypothesis for changes,
Virology 197 (1993) 1–11.
Page 7
670 Y. Xu et al. / Biochemical and Biophysical Research Communications 315 (2004) 664–670
[15] W.P. Michalski, G. Crameri, L. Wang, B.J. Shiell, B. Eaton, The
cleavage activation and sites of glycosylation in the fusion protein
of Hendra virus, Virus Res. 69 (2000) 83–93.
[16] R.A. Lamb, S.B. Joshi, R.E. Dutch, The paramyxovirus fusion
protein forms an extremely stable core trimer: structural parallels
to influenza virus haemagglutinin and HIV-1 gp41, Mol. Membr.
Biol. 16 (1999) 11–19.
[17] D.M. Eckert, P.S. Kim, Mechanisms of viral membrane fusion
and its inhibition, Annu. Rev. Biochem. 70 (2001) 777–810.
[18] W. Weissenhorn, A. Dessen, L.J. Calder, S.C. Harrison, J.J.
Skehel, D.C. Wiley, Structural basis for membrane fusion by
enveloped viruses, Mol. Membr. Biol. 16 (1999) 3–9.
[19] J. Bentz, Membrane fusion mediated by coiled coils: a hypothesis,
Biophys. J. 78 (2000) 886–900.
[20] J.J. Skehel, D.C. Wiley, Coiled coils in both intracellular vesicle
and viral membrane fusion, Cell 95 (1998) 871–874.
[21] J.J. Skehel, D.C. Wiley, Receptor binding and membrane fusion in
virus entry: the influenza hemagglutinin, Annu. Rev. Biochem. 69
(2000) 531–569.
[22] J.J. Skehel, K. Cross, D. Steinhauer, D.C. Wiley, Influenza fusion
peptides, Biochem. Soc. Trans. 29 (2001) 623–626.
[23] M. Lu, S.C. Blacklow, P.S. Kim, A trimeric structural domain of
the HIV-1 transmembrane glycoprotein, Nat. Struct. Biol. 2
(1995) 1075–1082.
[24] S.C. Blacklow, M. Lu, P.S. Kim, A trimeric subdomain of the
simian immunodeficiency virus envelope glycoprotein, Biochem-
istry 34 (1995) 14955–14962.
[25] L. Cuzin, M. Alvarez, Enfuvirtide for prophylaxis against HIV
infection, N. Engl. J. Med. 349 (2003) 2169–2170.
[26] K.N. Bossart, L.F. Wang, M.N. Flora, K.B. Chua, S.K. Lam,
B.T. Eaton, C.C. Broder, Membrane fusion tropism and hetero-
typic functional activities of the Nipah virus and Hendra virus
envelope glycoproteins, J. Virol. 76 (2002) 11186–11198.
[27] M. Singh, B. Berger, P.S. Kim, LearnCoil-VMF: computational
evidence for coiled-coil-like motifs in many viral membrane-fusion
proteins, J. Mol. Biol. 290 (1999) 1031–1041.
[28] J. Zhu, C.W.-H. Zhang, Y. Qi, P. Tien, G.F. Gao, The fusion
protein core of measles virus forms stable coiled-coil trimer,
Biochem. Biophys. Res. Commun. 299 (2002) 897–902.
[29] J.Q. Zhu, C.W.-H. Zhang, Z. Rao, P. Tien, G.F. Gao, Biochem-
ical and biophysical analysis of heptad repeat regions from the
fusion protein of Menangle virus, a newly emergent paramyxo-
virus, Arch. Virol. 148 (2003) 1301–1316.
[30] J. Zhu, P. Li, T. Wu, F. Gao, Y. Ding, C.W.-H. Zhang, Z. Rao,
G.F. Gao, P. Tien, Design and analysis of post-fusion 6-helix
bundle of heptad repeat regions from Newcastle disease virus F
protein, Protein Eng. 16 (2003) 373–379.
[31] J. Zhu, Y. Ding, F. Gao, T. Wu, C.W.-H. Zhang, P. Tien, Z. Rao,
G.F. Gao, Crystallization and preliminary X-ray crystallographic
analysis of the trimer core from measles virus fusion protein, Acta
Crystallogr. D Biol. Crystallogr. 59 (2003) 587–590.
[32] M. Yu, E. Wang, Y. Liu, D. Cao, N. Jin, C.W.-H. Zhang, M.
Bartlam, Z. Rao, P. Tien, G.F. Gao, Six-helix bundle assembly
and characterization of heptad repeat regions from the F protein
of Newcastle disease virus, J. Gen. Virol. 83 (2002) 623–629.
[33] E. Wang, X. Sun, Y. Qian, L. Zhao, P. Tien, G.F. Gao, Both
heptad repeats of human respiratory syncytial virus fusion protein
are potent inhibitors of viral fusion, Biochem. Biophys. Res.
Commun. 302 (2003) 469–475.
[34] P.Y. Li, J.Q. Zhu, B.L. Wu, F. Gao, P. Tien, Z. Rao, G.F. Gao,
Crystallization and preliminary X-ray diffraction analysis of post-
fusion six-helix bundle core structure from Newcastle disease virus
F protein, Acta Crystallogr. D Biol. Crystallogr. 59 (2003) 1296–
1298.
[35] M.G. Dordingley, P.L. Callahan, V.V. Sardana, V.M. Garsky,
R.J. Colonno, J. Biol. Chem. 265 (1990) 9062–9065.
[36] J.K. Young, R.P. Hicks, G.E. Wright, T.G. Morrison, Analysis of
a peptide inhibitor of paramyxovirus (NDV) fusion using biolog-
ical assays, NMR, and molecular modeling, Virology 238 (1997)
291–304.
[37] D. Rapaport, M. Ovadia, Y. Shai, A synthetic peptide correspond-
ing to a conserved heptad repeat domain is a potent inhibitor of
Sendai virus–cell fusion: an emerging similarity with functional
domains of other viruses, EMBO J. 14 (1995) 5524–5531.
[38] T.F. Wild, R. Buckland, Inhibition of measles virus infection and
fusion with peptides corresponding to the leucine zipper region of
the fusion protein, J. Gen. Virol. 78 (1997) 107–111.
[39] S.B. Joshi, R.E. Dutch, R.A. Lamb, A core trimer of the
paramyxovirus fusion protein: parallels to influenza virus hemag-
glutinin and HIV-1 gp41, Virology 248 (1998) 20–34.
[40] K.A. Baker, R.E. Dutch, R.A. Lamb, T.S. Jardetzky, Structural
basis for paramyxovirus-mediated membrane fusion, Mol. Cell 3
(1999) 309–319.
[41] X. Zhao, M. Singh, V.N. Malashkevich, P.S. Kim, Structural
characterization of the human respiratory syncytial virus fusion
protein core, Proc. Natl. Acad. Sci. USA 97 (2000) 14172–14177.